TL Genomics
Koganei
About TL Genomics
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.The company isolates fetal cells in maternal blood using a uniquely developed technology and examines the genome of the fetal cells, enabling noninvasive and definitive diagnosis of fetal chromosomal disease early in pregnancy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.8M
- Last round: Grant (Mar 2026)
- Website: tlgenomics.com
- Phone: +81 0466-47-8655
Industries & Categories
Health Care, Medical Device, Task Management
Canonical: https://fsome.com/organization/tl-genomics-197401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.